Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.
The current price of HAE is $76.91 USD — it has decreased by -1.65% in the past 24 hours. Watch Haemonetics stock price performance more closely on the chart.
What is Haemonetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Haemonetics stocks are traded under the ticker HAE.
Is Haemonetics stock price growing?▼
HAE stock has fallen by -2.29% compared to the previous week, the month change is a +36.63% rise, over the last year Haemonetics has showed a +9.93% increase.
What is Haemonetics market cap?▼
Today Haemonetics has the market capitalization of 3.57B
When is the next Haemonetics earnings date?▼
Haemonetics is going to release the next earnings report on August 11, 2026.
What were Haemonetics earnings last quarter?▼
HAE earnings for the last quarter are 1.29 USD per share, whereas the estimation was 1.27 USD resulting in a +1.36% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Haemonetics revenue for the last year?▼
Haemonetics revenue for the last year amounts to 2.72B USD.
What is Haemonetics net income for the last year?▼
HAE net income for the last year is 335.36M USD.
How many employees does Haemonetics have?▼
As of June 16, 2026, the company has 3,657 employees.
In which sector is Haemonetics located?▼
Haemonetics operates in the Health & Wellness sector.
When did Haemonetics complete a stock split?▼
The last stock split for Haemonetics was on December 03, 2012 with a ratio of 2:1.
Where is Haemonetics headquartered?▼
Haemonetics is headquartered in Boston, United States.